An important characteristic of the transcription of a ribosomal RNA gene (rDNA) mediated by DNA-dependent RNA polymerase (Pol) I is its stringent species specificity. SL1/TIF-IB is a key complex for species specificity, but its functional complex has not been reconstituted. Here, we established a novel and highly sensitive monitoring system for Pol I transcription to reconstitute the SL1 activity in which a transcript harboring a reporter gene synthesized by Pol I is amplified and converted into translatable mRNA by the influenza virus RNA-dependent RNA polymerase. Using this monitoring system, we reconstituted Pol I transcription from the human rDNA promoter in mouse cells by expressing four human TATA-binding protein (TBP)-associated factors (TAF I s) in the SL1 complex. The reconstituted SL1 also re-activated human rDNA transcription in mouse A9 cells carrying an inactive human chromosome 21 that contains the rDNA cluster. Chimeric SL1 complexes containing human and mouse TAF I s could be formed, but these complexes were inactive for human rDNA transcription. We conclude that four human TAF I s are necessary and sufficient to overcome the barrier of species specificity for human rDNA transcription in mouse cells.
INTRODUCTION
One of the most important rDNA transcription issues to be addressed is the molecular mechanism of its stringent species specificity (Heix and Grummt, 1995) . Three decades ago, Grummt et al. demonstrated that in vitro transcription of human and mouse rDNAs requires completely homologous extracts (Grummt, 1981; Grummt et al., 1982) , i.e. human rDNA is not transcribed in mouse cell extracts and vice versa. This distinct promoter recognition specificity of Pol I is mediated by a multisubunit factor called SL1 in humans and TIF-IB in mice. SL1/ TIF-IB recruits Pol I on the rDNA promoter through RRN3/TIF-IA and stabilizes the binding of the upstream binding factor (UBF) at the rDNA promoter (Friedrich et al., 2005; Moss and Stefanovsky, 2002; Russell and Zomerdijk, 2006) . Pol I, UBF and TIF-IA are functionally interchangeable between humans and mice, whereas the SL1/TIF-IB complex must be derived from the same species to support rDNA transcription (Bell et al., 1990; Heix and Grummt, 1995; Learned et al., 1985; Mishima et al., 1982; Rudloff et al., 1994; Schnapp et al., 1993) . The human SL1 complex contains the TATA-binding protein (TBP) and three TBP-associated factors known as TAF I A (also known as TAF I 48 and TAF1A), TAF I B (also known as TAF I 63 and TAF1B) and TAF I C (also known as TAF I 110C and TAF1C) (Comai et al., 1992) . Among these SL1 components, TBP is interchangeable between humans and mice, indicating that TAF I s are responsible for the promoter selectivity of SL1/TIF-IB (Rudloff et al., 1994) . UV cross-linking experiments have demonstrated that TAF I A and TAF I B bind to both the homologous and heterologous promoters, suggesting that a binding of SL1/TIF-IB to the heterologous promoter precludes a formation of productive initiation complexes (Rudloff et al., 1994) . There are contradictory reports about reconstituting SL1/TIF-IB activity in vitro. It has been reported that the three recombinant human TAF I s and the TBP are necessary and sufficient to reconstitute a transcriptionally active human SL1 complex (Zomerdijk et al., 1994) . In contrast, three mouse recombinant TAF I s and the TBP complex did not reconstitute the TIF-IB activity in an in vitro transcription system (Heix et al., 1997) . Later, a further TAF I , TAF I D (also known as TAF I 41 and TAF1D), was identified from the TBP-antibody affinity-purified SL1 fraction (Gorski et al., 2007) . TAF I D co-migrates with TBP on SDS-PAGE, so it remained unidentified for more than 10 years following the initial identification of the SL1 complex (Comai et al., 1992) . TAF I D is involved in rDNA transcription in vivo (Gorski et al., 2007) . Thus, we hypothesize that TAF I D is a final component in reconstituting the human SL1 activity in mouse cells and overcoming the rDNA transcription species barrier.
To examine this hypothesis, we established a novel and highly sensitive monitoring system for Pol I transcription. The products synthesized by Pol I are not translated to proteins. We tried to overcome this problem using the influenza virus RNA-dependent RNA polymerases (RdR Pol). Influenza A virus belongs to the Orthomyxoviridae family, and its genome comprises eight single-stranded RNAs of negative polarity (Naito et al., 2007) . The viral RNA (vRNA) is associated with the viral RdR Pol, comprising PB1, PB2 and PA subunits, and nucleoprotein (NP), forming viral ribonucleoprotein (vRNP) complexes Portela and Digard, 2002) . The transcription promoter and the replication signal of the viral genome exist at the 39 and 59 untranslated terminal regions (UTRs) of each segment. Transcription of the influenza virus genome is initiated by the cap snatching mechanism (Li et al., 2001) . The viral RdR Pol polyadenylates the nascent RNA chain, possibly by a slippage mechanism at the adenylation signal which consists of five to seven uracil residues located near the 59 terminal of vRNA (Poon et al., 1999) . Thus, the synthesized RNA has the authentic eukaryotic mRNA structure. An influenza-virus-like particle generation system was established based on the transfection of plasmid DNAs containing the viral genes under the control of the Pol I promoter and terminator (Neumann et al., 1999; Zobel et al., 1993) . In this system, an influenza virus genome RNA of an exact size and orientation is synthesized by cellular Pol I. When the viral coding region is replaced with a reporter gene (see Fig. 1A ), the reporter gene is expressed through the viral system described above. We examined the mechanism of rDNA transcription. In particular, we evaluated its species-specific property using this novel and highly sensitive assay system, as we considered the possibility that the species-specificity contradiction might be caused by reconstituted Pol I with an activity less than the detectable level of conventional assay systems.
In the present study, we established a viral RdR Pol-based reporter system to monitor Pol I transcription. Using this monitoring system, we succeeded in reconstituting Pol I transcription from human rDNA in mouse cells by exogenously expressing human TAF I A, B, C and D in the SL1 complex, but not with human TAF I A, TAF I B and TAF I C. Exogenous expression of four TAF I s not only induced transcription from the human rDNA promoter in a reporter plasmid but also reactivated human rDNA in mouse cells containing the human chromosome 21 carrying an inactive human rDNA cluster. These results indicate that four TAF I s in human SL1 are necessary and sufficient to reconstitute a transcriptionally active SL1 and overcome the barrier of species specificity during rDNA transcription in mouse cells.
RESULTS
A novel reporter assay system for transcription by Pol I
We developed a novel and sensitive reporter assay system to monitor transcription by Pol I in order to precisely analyze the species barrier for rDNA transcription (Fig. 1A) by modifying the original method (Zobel et al., 1993) for the influenza-virus-like particle generation system. In this system, engineered vRNA containing a firefly luciferase (Luc) gene or an EGFP gene sandwiched between 59-and 39-terminal cis-acting regulatory regions is synthesized by Pol I under the control of the promoter and terminator in transfected cells. PA, PB1, PB2 and NP are supplied from expression vectors under the control of the Pol II promoter (Neumann et al., 1999) . mRNA encoding Luc is synthesized by the influenza viral RdR Pol using RNA transcribed by Pol I as a template and the cellular cap structure as a primer (Li et al., 2001; Poon et al., 1999) . The synthesized RNA is a typical form of eukaryotic mRNA and is thereby subjected to translation after its transport from the nucleus to the cytoplasm. First, we examined whether this reporter system was dependent on viral components (Fig. 1B) . phPolI-vNS-Luc contains an Luc gene of reverse orientation sandwiched between 59-and 39-terminal UTRs of the influenza virus (A/ WSN/33) segment 8, which encodes a nonstructural (NS) protein.
As expected, the Luc activity was detected in HeLa cells expressing all components of this system (Fig. 1B, lane 6) . Although phPolI was originally called pHH21 or pPolI in a previous report (Neumann et al., 1999) , we designated this plasmid as phPolI because it makes it easy to distinguish plasmids carrying the human or mouse rDNA promoter. Next, we evaluated this system by comparing it with an internal ribosome entry site (IRES)-mediated reporter system (Hannan et al., 1996; Palmer et al., 1993) . In the IRES-mediated reporter system for Pol I used by Palmer et al., activity relative to the background was increased ,30-fold. In our experiments, the IRES-mediated reporter system did not produce a significant level of the Luc activity (Fig. 1C, lanes 3 and 4) . In the RdR Polmediated system described above, the Luc activity was .10 4 -fold higher than the background activity. These results show that the RdR Pol-mediated system is highly sensitive for monitoring Pol I activity. We also constructed a reporter system expressing EGFP. The EGFP signal was observed in the presence of four viral components, whereas it was not observed in the absence of NP (Fig. 1D) .
Evaluation of the RdR Pol-based reporter system for Pol I Next, we confirmed the reliability of the RdR Pol-based reporter system for monitoring transcription by Pol I. We constructed three reporter plasmids carrying the human rDNA promoter with mutations at residues that abrogate activity (Grummt, 1982; Grummt, 1998; Haltiner et al., 1986; Jones et al., 1988; Kishimoto et al., 1985; Miller et al., 1985; Moss and Stefanovsky, 1995) . As shown in Fig. 2A ,B, phPolI-DCore-vNS-Luc and phPolI-DUCEvNS-Luc lacked the core and upstream control elements of the human rDNA promoter, respectively. G residues at 27 and 216 relative to the transcription initiation site are quite important for the transcription of the mammalian rRNA gene. These G residues are replaced with A residues in phPolI-G-7,-16A-vNS-Luc. The RdR Pol-mediated Luc activity driven by phPolI-DCore-vNS-Luc in HeLa cells was completely eliminated (Fig. 2C, lanes 4 and 5) . In addition, the RdR Pol-mediated Luc activity driven by phPolI-DUCE-vNS-Luc and phPolI-G-7,-16A-vNS-Luc in HeLa cells were ,10% of that driven by phPolI-v-NS-Luc (Fig. 2C, lanes 6-9) . These results were consistent with previous reports about the properties of the rDNA promoter.
We also constructed the pmPolI-vNS-Luc reporter plasmid, which carries the mouse rRNA gene promoter instead of the human rRNA gene promoter in phPolI-vNS-Luc. Although pmPolI was originally called as pHMP1 in a previous report (Turan et al., 2004) , we redesignated this plasmid pmPolI because it makes it easy to distinguish plasmids carrying the human or mouse rDNA promoter. As shown in the human reporter system, we constructed three reporter plasmids carrying mutations in the mouse rDNA promoter that abrogate activity (Fig. 2D,E) . There was no RdR Pol-mediated Luc activity driven by pmPolI-DCorevNS-Luc in mouse NIH3T3 cells (Fig. 2F, lanes 4 and 5) . The RdR Pol-mediated Luc activity driven by pmPolI-DUCE-vNSLuc and pmPolI-G-7,-16A-vNS-Luc in mouse NIH3T3 cells was dramatically lower compared with that by pmPolI-v-NS-Luc (Fig. 2F, lanes 6-9) . These results clearly demonstrate that our RdR-mediated reporter system detects Pol I activity.
The transcription rate of rDNA by Pol I is closely correlated with the cell growth rate and depends on the cell culture conditions (Grummt, 1999) . We examined RdR Pol-mediated Luc activity in HeLa cells maintained with 0.5%, 2% and 10% serum (supplementary material Fig. S1A ). The Pol I transcription level, as monitored by the Luc activity, increased in a serumconcentration-dependent manner, as previously reported by conventional assay systems monitoring the incorporation of [ 3 H]uridine into the 45S rRNA precursor (Stefanovsky et al., 2006) . Furthermore, we confirmed that the RdR Pol-based reporter system responded to exogenous expression of UBF, an essential transcription factor for transcription by Pol I (supplementary material Fig. S1B,C ; Grummt, 1999) . CX-5461 inhibits Pol I via the disruption of SL1 recruitment on the rDNA promoter (Drygin et al., 2011) . Treatment with CX-5461 reduced the Luc activity in the RdR Pol-based reporter system when normalized to c-Myc-or b-actin-encoding mRNAs as previously described (Drygin et al., 2011) (supplementary material Fig.  S1D ). Taken together, we conclude that this RdR Pol-based reporter system is highly sensitive and useful for analyzing the transcription mechanism by Pol I.
In vivo reconstitution of human rDNA transcription in mouse cells
We used the RdR Pol-based reporter system to uncover the molecular mechanism underlying the species-specific transcription by Pol I. phPolI and pmPolI, used in Fig. 3 , contain the human and mouse Pol I promoters, respectively (Neumann et al., 1999; Turan et al., 2004) . In human HeLa cells, the Luc activity was observed in the presence of viral RdR Pol components and NP (Fig. 3, 3Pol+NP ) when the human Pol I vector (phPolI-vNS-Luc) was transfected. In contrast, the Luc activity was not detected when the mouse Pol I vector (pmPolI-vNS-Luc) was transfected (Fig. 3A, upper panel) . Furthermore, the mouse reporter, but not the human reporter, showed Luc activity in mouse NIH3T3 cells (Fig. 3A , lower panel). These results indicate that species-specific transcription by Pol I is reproduced in the RdR Pol-based reporter system.
To reconstitute the human SL1 activity in mouse cells, we cloned four human TAF I s (hTAF I s) and performed immunoblotting using extracts from 293T cells transfected with vectors encoding hTAF I s (Fig. 3B ). The effect of hTAF I s on transcription from the human rDNA promoter was examined in NIH3T3 cells using the RdR Pol-based reporter system for Pol I. The human rDNA promoter was not transcribed in NIH3T3 cells without the human SL1 complex or even in the presence of the three factors: hTAF I A, hTAF I B, and hTAF I C (Fig. 3C , lanes 3 and 5). In sharp contrast, with hTAF I A, hTAF I B, hTAF I C and hTAF I D (Fig. 3C , lanes 4 and 6) Luc activities were detected from the human reporter (phPolI-vNS-Luc). Next, NIH3T3 cells were co-transfected with the human reporter plasmid in the presence of all combinations of hTAF I s (Fig. 3D) . No combination of the three hTAF I s reconstituted the efficient transcription activity driven by the human rDNA promoter (Fig. 3D , lanes 3-6), although a low transcription level was observed when either hTAF I A or hTAF I B was omitted. Importantly, human rDNA transcription was not at all stimulated in NIH3T3 cells when a single factor or any combination of two factors were expressed (Fig. 3D , lanes 7-16). These results indicate that the four hTAF I s are required for maximum transcription from the human Pol I promoter in mouse cells. In addition, hTAF I C and hTAF I D played an essential role in the SL1 activity and species specificity (Fig. 3D , lanes 3 and 4), and mouse TAF I A (mTAF I A) and mTAF I B could partially replace human cognate proteins for human rDNA transcription in mouse cells (Fig. 3D , lanes 5 and 6). This finding is consistent with that from UV crosslinking experiments stating that TAF I A and TAF I B bind to both homologous and heterologous promoters (Rudloff et al., 1994) . As a control, we examined the effect of all combinations of hTAF I s on the mouse reporter system in NIH3T3 cells (supplementary material Fig. S2 ). Exogenous expression of the four hTAF I s did not increase the level of the mouse Pol I activity but rather interfered with mouse Pol I activity. Taken together, the four hTAF I s in human SL1 are necessary and sufficient to reconstitute a transcriptionally active SL1 and overcome the barrier of species specificity in human rDNA transcription in mouse cells.
Transcriptional reactivation of inactive human rDNA in A9 cells
As shown above, the RdR Pol-based reporter system was sensitive for detecting Pol I activity. However, we could not completely exclude the possibility that human rDNA was transcribed in mouse cells by an unexpected effect between RdR Pol and the four hTAF I s. To exclude this possibility and directly show the function of the human SL1 in mouse cells, we used mouse A9 cells carrying a single intact human chromosome 21 (A9ch21 cells), which contains human rDNAs, but not any human TAF I genes (Cuthbert et al., 1995) . Human rDNA transcription could not be detected in A9ch21 cells (Fig. 4A , left panel). Because the inactive human rDNA promoter region was reported to be highly methylated (Guetg et al., 2012; Santoro and Grummt, 2001) , we examined the DNA methylation pattern on human rDNAs in A9ch21 cells using methylation-sensitive (HpaII) and -insensitive (MspI) restriction enzymes. Although human rDNAs were transcriptionally inactive in A9ch21 cells, .40% of human rDNA promoters were unmethylated, and the methylation status of the human rDNA promoter was not significantly different from that of the mouse rDNA promoters in A9ch21 cells (Fig. 4B) . Moreover, the epigenetic profile on the human rDNA promoter in A9ch21 cells was examined by chromatin immunoprecipitation (ChIP) assays. Both acetylation and trimethylation at histone H3 lysine 9 (H3K9) on human rDNAs were slightly higher than those on mouse rDNAs in A9ch21 cells (Fig. 4C ). In addition, the amount of UBF bound to the human rDNA promoter in A9ch21 cells was quite low. However, micrococcal nuclease (MNase) digestion assays demonstrated that the human rDNA promoter region was more resistant to MNase than the mouse rDNA promoter in A9ch21 cells comprising both active and inactive rDNAs (Fig. 4D) . These results suggest that inactive human rDNAs are not assembled into a typical heterochromatin structure in mouse cells, but they rather just form compact chromatin structure resistant to nuclease.
Next, we examined the effect of exogenous hTAF I s expression on transcription from the human rDNA promoter in A9ch21 cells. First, we confirmed that the SL1 activity was reconstituted by four exogenously expressed hTAF I s in A9ch21 cells (Fig. 4E) . We then examined transcription from human rDNA in A9ch21 cells in the presence of the four hTAF I s. Total RNA was prepared from A9ch21 cells transiently expressing hTAF I s, followed by quantitative RT-PCR using primer sets for human 45S pre-rRNA. The inactive human rDNA in mouse cells was reactivated by four exogenously expressed hTAF I s (Fig. 4F) . Human pre-rRNA could not be observed in A9ch21 cells in the absence of TAF I D (Fig. 4G, lane 2) . These results indicate that human rDNA transcription was reconstituted by four hTAF I s in mouse A9ch21 cells in addition to that monitored by the RdR Pol-based reporter system.
Formation of a chimeric SL1 complex
Human rDNA transcription in mouse cells required four hTAF I s, whereas three hTAF I A, hTAF I B and hTAF I C did not confer transcription, as shown in Figs 3 and 4. It is possible that hTAF I A, hTAF I B and hTAF I C cannot interact with mouse TAF I D (mTAF I D). To examine this hypothesis, Flag-tagged mTAF I D was co-expressed with HA-tagged hTAF I A, hTAF I B and hTAF I C in 293T cells, followed by immunoprecipitation with anti-Flag antibody. HA-tagged hTAF I A, hTAF I B and hTAF I C coimmunoprecipitated with Flag-tagged mTAF I D, as they were with Flag-tagged hTAF I D (Fig. 5A) . Endogenous TBP was also co-immunoprecipitated with Flag-tagged hTAF I D and mTAF I D (Fig. 5B) . These results indicate that mTAF I D is able to form a chimeric SL1 complex, including TBP and hTAF I A, hTAF I B and hTAF I C, in agreement with a previous report (Heix et al., 1997) . Furthermore, Flag-tagged mTAF I D formed a chimeric SL1 complex with HA-tagged hTAF I A, hTAF I B and hTAF I C, and endogenous TBP did not confer transcription of human rDNA (Fig. 5C, lane 4) . In addition, no combination of three hTAF I s and a single mTAF I conferred maximum transcription of human rDNA, which was driven by four hTAF I s (supplementary material Fig. S3A ). These data suggest that any chimeric SL1 complex comprising three hTAF I s and a single mTAF I cannot form functional SL1 complexes.
Chimeric SL1 complexes did not bind to the human rDNA promoter UV crosslinking experiments have demonstrated that TAF I A and TAF I B bind to both homologous and heterologous promoters (Rudloff et al., 1994) . This report encouraged us to examine whether the mouse SL1/TIF-IB complex and chimeric complex are associated with the human rDNA promoter in mouse A9 cells carrying the human chromosome 15 (A9ch15 cells). The four exogenously expressed hTAF I s activated transcription of human rDNA in A9ch15 and A9ch21 cells (supplementary material Fig.  S3B ). The reactivation level of human rDNA transcription in A9ch15 cells by the four hTAF I s was 9.1-fold higher than that of A9ch21 cells (supplementary material Fig. S3C ). Therefore, we used A9ch15 cells instead of A9ch21 cells for additional ChIP assays. We performed ChIP assays using anti-TBP antibody. TBP bound to the mouse rDNA promoter, but not to the human rDNA promoter, in mouse A9ch15 cells (Fig. 6A, left panel) . However, TBP bound to the human rDNA promoter in HeLa cells (Fig. 6A,  right panel) . These results clearly indicate that the mouse SL1/ TIF-IB complexes cannot associate with the human rDNA promoter. As shown in Fig. 6B , the four exogenously expressed human TAF I s recruited TBP on the human rDNA promoter in A9ch15 cells. In contrast, chimeric SL1 complexes and four mTAF I s could not recruit TBP on the human rDNA promoter in A9ch15 cells compared with the four hTAF I s. Furthermore, the occupancy of UBF at the human rDNA promoter increased slightly in A9ch15 cells in the presence of the four exogenous hTAF I s (Fig. 6C) , which is in good agreement with a report stating that human SL1 stabilizes the binding of UBF at the human rDNA promoter (Friedrich et al., 2005) . A large amount of RPA194, the largest subunit of Pol I, was also recruited on human rDNA in mouse A9ch15 cells by the four exogenously expressed human TAF I s. We conclude that SL1 complexes comprising four human TAF I s are required for the recognition of the human rDNA promoter.
DISCUSSION
In this report, we describe an RdR Pol-based reporter system for transcription by Pol I. The RdR Pol-based reporter system showed high sensitivity, because RNA synthesized by Pol I is amplified and converted into translatable mRNA by RdR Pol. Transcription of human rDNA was reconstituted in mouse cells by exogenously expressing four TAF I s from the human SL1 complex. In addition, we demonstrated that silent human rDNA transcription in mouse A9ch21 cells was reactivated by the four exogenously expressed hTAF I s. These results suggest that the four human TAF I s are necessary and sufficient to overcome the species-specific barrier of human rDNA transcription in mouse cells. It has been reported that the human SL1 activity can be reconstituted in vitro by the three recombinant hTAF I s, hTAF I A, hTAF I B and hTAF I C, in addition to recombinant TBP, with a relatively higher background (Zomerdijk et al., 1994) . Those authors used DNA-affinity-purified UBF and recombinant hTAF I A, hTAF I B, hTAF I C and TBP for reconstituting in vitro transcription by Pol I. Furthermore, it has been shown that UBF interacts with hTAF I D in vivo and in vitro (Gorski et al., 2007) . Based on those results, it is quite likely that a low level of hTAF I D, which was associated with either DNA-affinity-purified UBF or the purified Pol I fraction, was present in their in vitro reaction. This assumption is supported by a report that mouse TIF-IB activity is not reconstituted by recombinant protein of three mTAF I s, mTAF I A, mTAFB and mTAFC, in addition to recombinant TBP and UBF (Heix et al., 1997) . Taken together, we conclude that hTAF I D is the putative final component in completing the SL1 activity.
The four mouse TAF I A, TAF I B, TAF I C and TAF I D proteins show 90%, 87%, 75% and 68% similarity, respectively, to their human counterparts, according to BLAST2 (NCBI) analyses. Their similarity is in good agreement with the observation that TAF I A and TAF I B are partially replaceable for human cognate proteins, whereas TAF I C and TAF I D have crucial roles in species specificity, as shown in Fig. 3D . We found that mouse Flagtagged TAF I D forms a complex with human HA-tagged TAF I A, TAF I B, TAF I C and TBP (Fig. 5 ). This result is partially supported by a report that mouse and human TAF I s (hTAF I A, hTAF I B and hTAF I C) can form chimeric TBP-TAF I complexes (Heix et al., 1997 ). It appears that subtle differences between individual TAF I s might affect the overall conformation of the chimeric complex between TBP and the TAF I s, which could be transcriptionally inactive, as mentioned by Heix and Grummt (Heix and Grummt, 1995) . Our results clearly indicate that the human SL1 activity requires four hTAF I s, at least in mouse cells. For further analysis of the molecular mechanism of the promoter selectivity by Pol I, SL1/TIF-IB activity should be reconstituted in vitro by four TAF I s and TBP recombinant proteins.
Although the human SL1 activity was reconstituted in mouse cells, the four mouse TAF I s did not confer transcription of mouse rDNA in HeLa cells (supplementary material Fig. S4 ). These results are consistent with a report that the human SL1 can reprogram mouse nuclear extracts during in vitro transcription from the human rDNA promoter (Learned et al., 1985) , but TIF-IB cannot reprogram human nuclear extracts during in vitro transcription from the mouse rDNA promoter (Schnapp et al., 1991) . TIF-IB requires mouse Pol I to reprogram human nuclear extracts, whereas mouse SL1/TIF-IB, human UBF and human Pol I can reconstitute transcription from the mouse rDNA promoter in vitro (Bell et al., 1990; Schnapp et al., 1991) . It is assumed that there is an unknown factor(s) preventing TIF-IB activity in HeLa cells, suggesting that the species barrier(s) to rDNA transcription might be different between humans and mice.
The level of SL1/TIF-IB in cells is too low to study the molecular mechanism of promoter recognition and speciesspecific transcription by Pol I (Heix et al., 1997) . Thus, to confirm the exogenous expression of hTAF I s, we performed immunoblotting using extracts from 293T cells transfected with vectors encoding hTAF I s (Fig. 3B) . Despite considerable efforts, exogenously expressed TAF I s were not detected by immunoblotting using NIH3T3, A9ch15, A9ch21 or HeLa cell extracts. In these cells, the abundance of SL1 might be under the control of an unknown mechanism, whereas 293T cells lack the possible mechanism, which keeps the SL1 level low. Similarly, the p53 tumor suppressor protein level and activity are controlled by a ubiquitin-proteasome pathway involving MDM2 (Hock and Vousden, 2014) . The possible mechanism to maintain a low level of SL1 is currently an open question.
We used two mouse A9 cell lines (A9ch21 and A9ch15) carrying a human chromosome to show the SL1 activity in the presence of four human TAF I s. During the course of this study, we found that the level of human rDNA transcription in A9ch15 cells was 9.1-fold higher than that in A9ch21 cells in the presence of the four human TAF I s (supplementary material Fig. S3C ). The human rDNA copy number in an A9ch15 cell was smaller than that in an A9ch21 cell (supplementary material Fig. S3D) . Notably, the level of DNA methylation on the human rDNA promoter in A9ch15 cells was significantly lower than that in A9ch21 cells (supplementary material Fig. S3E ). The level of DNA methylation on the promoter may determine the level of response to exogenous expression of the four human TAF I s. In addition, the maintenance of the DNA methylation level on the human rDNA promoter was independent of human rDNA transcription in mouse A9 cells. Noncoding promoter RNA (pRNA) synthesized by RNA polymerase I recruits PARP1 and NoRC complexes to rDNA, so pRNA is involved in the formation and maintenance of silent rDNA chromatin (Guetg et al., 2012; Mayer et al., 2006; Santoro et al., 2010) . Nucleolar localization of NoRC in NIH3T3 cells is mediated by pRNAs synthesized from mouse and human rDNA proximal Pol I promoters (Mayer et al., 2008) . The results shown in supplementary material Fig. S3 raise fundamental questions whether mouse pRNA is involved in DNA methylation on human rDNA promoter, and whether human pRNA is transcribed by mouse Pol I machinery. In conclusion, the A9 cell line carrying human chromosomes 15 and 21 may provide a good model system for studying rDNA epigenetics.
Studies on the mechanism of rDNA transcription mediated by Pol I have become a focus again. It is well known that the regulation of rDNA transcription is related to cancer cell proliferation (White, 2005) . c-Myc, a representative transcription factor involved in tumorigenesis, binds to rDNA and increases rDNA transcription (Arabi et al., 2005; Grandori et al., 2005) . Several protein kinases, including casein kinase II and ERK, have the ability to upregulate rDNA transcription through the phosphorylation of UBF and TIF-IA in cancer cells (Bierhoff et al., 2008; Lin et al., 2006; Panova et al., 2006; Stefanovsky et al., 2001 ). Thus, the Pol I transcription machinery is being reevaluated as an emerging target for treating cancer (Drygin et al., 2010; Hein et al., 2013) . It is possible that the RdR Pol-based reporter system for Pol I activity would be a convenient and highly sensitive tool for monitoring Pol I activity and screening inhibitors for Pol I transcription.
MATERIALS AND METHODS

Cell cultures and luciferase assay
HeLa cells, NIH3T3 cells, A9ch15 cells and A9ch21 cells were used for transfection experiments. They were maintained at 37˚C in Dulbecco's modified Eagle's medium (Nissui) supplemented with 10% fetal bovine serum. In addition, A9ch15 cells and A9ch21 cells were cultured in the presence of 50 mg/ml hygromycin B (InvivoGen) to keep the human chromosome in the mouse cells. The Luc and the Renilla Luc activities were determined using Luciferase assay reagent (Promega) and the Renilla Luciferase Assay System (Promega) according to the manufacturer's protocol. The relative luminescence intensity was measured for 10 seconds with a MiniLumat (Berthold).
DNA transfection
Cells were transfected with DNA using Lipofectamine 2000 (Invitrogen) or GeneJuice (Novagen) transfection reagent kit according to the manufacturers' instructions. For Fig. 1B , HeLa cells were cotransfected with 25 ng each of pCAGGS-PA, pCAGGS-PB1, pCAGGS-PB2, pCAGGS-NP (Kawaguchi et al., 2005; Naito et al., 2007) , which leads to synthesis of PA, PB1, PB2 and NP mRNAs, respectively, by Pol II, 90 ng of phPolI-vNS-Luc and 10 ng of pRL-SV40 (lane 6). Assays were also carried out under omission of either one of the plasmids encoding viral components (Fig. 1D, left panels) . Transfection was also carried out with the omission of the plasmid encoding NP (Fig. 1D, right panels) . For Fig. 2C , HeLa cells were transfected with one of phPolI-based plasmids (90 ng), pRL-SV40 (10 ng) for expression of Renilla Luc, and plasmids (each 25 ng) expressing PA, PB1 and PB2 subunits, and NP. For Fig. 2F , NIH3T3 cells were transfected with one of pmPolI-based plasmids (90 ng), pRL-SV40 (10 ng) for expression of Renilla Luc, and plasmids (each 25 ng) expressing PA, PB1 and PB2 subunits, and NP. For Fig. 3C , NIH3T3 cells were transfected with pCHA-TAF I A, pCHA-TAF I B, pCHA-TAF I C and pCHA-TAF I D (25 ng for each) as indicated below each lane in the presence of the plasmid set (3Pol+NP) for the RdR Pol-based reporter system: phPolI-vNS-Luc (45 ng), pCAGGS-PA (11.3 ng), pCAGGS-PB1 (11.3 ng), pCAGGS-PB2 (11.3 ng), pCAGGS-NP (11.3 ng) and pRL-SV40 (10 ng). NIH3T3 cells were transfected with pCFlag-TAF I A, pCFlag-TAF I B, pCFlag-TAF I C and pCFlag-TAF I D (25 ng for each) as indicated below each lane in the presence of plasmid set (100 ng) for the RdR Pol-based reporter system. The total amount of plasmid DNA was adjusted to 200 ng with the empty plasmid pCHA or pCFlag. For  Fig. 3D , NIH3T3 cells were transfected with the plasmid set (100 ng) for the RdR Pol-based reporter system as mentioned in Fig. 3C , and together with pCHA-based plasmids encoding TAF I s, as indicated below each lane (25 ng each). The total amount of plasmid DNA was adjusted to 200 ng with empty plasmid, pCHA. The Luc assay was carried out at 48 hours post transfection. For Fig. 4E , A9ch21 cells were transfected with pCHA-TAF I A, pCHA-TAF I B, pCHA-TAF I C and pCHA-TAF I D (50 ng for each) as indicated below each lane in the presence of plasmid set for the RdR Pol-based reporter system: phPolI-vNS-Luc (90 ng), pCAGGS-PA (22.6 ng), pCAGGS-PB1 (22.6 ng), pCAGGS-PB2 (22.6 ng), pCAGGS-NP (22.6 ng) and pRL-SV40 (20 ng). For  Fig. 4F ,G, A9ch21 cells were transfected with pCHA-TAF I A, pCHA-TAF I B, pCHA-TAF I C and pCHA-TAF I D (100 ng for each) as indicated below each lane. Total amount of plasmid DNA was adjusted to 400 ng with empty plasmid, pCHA.
Immunoblotting and ChIP
Antibodies specific for Flag epitope tag (Sigma; M2), actin b (Sigma; AC-74), UBF (Santa Cruz Biotechnology; H-300), acetylated histone H3 (Upstate/Millipore), tri-methylated histone H3K9 (Abcam; ab8898), RPA194 (Santa Cruz Biotechnology; C-1) and TBP (Abcam; 51841), were used for immunoblotting and the ChIP assay. Immunoblotting was carried out essentially as described previously (Murano et al., 2008) . ChIP assays were performed according to the manual for the ChIP assay kit (Upstate). Quantitative PCR was carried out using FastStart SYBR Green Master (Roche) in the presence of primer sets, 59-AAGCCC-TCTCTGTCCCTGTCAC-39 and 59-GGAGAACTGATAAGACCGAC-AGGT-39 for the mouse rRNA gene (rDNA) promoter, 59-TTGA-CCAGAGGGACCCCGG-39 and 59-AATAACCCGGCGGCCCAAA-ATG-39 for the human rDNA promoter.
Restriction enzyme and MNase sensitivity assays
CpG methylation was assayed by digestion with HpaII (a methylationsensitive restriction enzyme) and MspI (a methylation-insensitive restriction enzyme) as described previously (Guetg et al., 2012; Santoro et al., 2002) . Genomic DNA (500 ng) prepared from A9ch21 cells was digested with 20 units of HpaII or MspI for 3 hours at 37˚C. Resistance to restriction enzymes was determined by quantitative PCR using FastStart SYBR Green Master (Roch) in the presence of a primer set, 59-AAGCCCTCTCTGTCCCTGTCAC-39 and 59-GGAGAACTGA-TAAGACCGACAGGT-39 for the mouse rDNA promoter, and 59-TTGACCAGAGGGACCCCGG-39 and 59-AATAACCCGGCGGCCCA-AAATG-39 for the human rDNA promoter. Nucleotide positions of 2262 bp (where '2' indicates the position upstream of the transcription site) for the mouse promoter, and 2167 bp, 290 bp, 262 bp and 256 bp for the human promoter relative to the transcription start site were found to be methylated, and the methylation sites were located between the forward and reverse primer positions.
For the MNase-sensitivity assay, A9ch21 cells ( 5610 5 ) were fixed in 1% formaldehyde, followed by permeabilization with MNase buffer (15 mM Tris-HCl pH 7.4, 15 mM NaCl, 60 mM KCl, 2 mM CaCl 2 , 0.5 mM DTT, 0.1% NP-40). Permeabilized cells were treated with MNase (Worthington Biochemical Corporation) at 37˚C for 10 minutes, and then the reaction was stopped by same volume of 26Protein K buffer (20 mM Tris-HCl pH 7.9, 10 mM EDTA, 1% SDS). The reaction was incubated at 95˚C for 15 minutes for reversal of crosslinking, followed by treatment with RNase A and Proteinase K for purification of DNA. The resistance to MNase was determined by quantitative PCR using FastStart SYBR Green Master (Roch) in the presence of a primer sets, 59-ACCTCCCCAGGTATGACTTCCAG-39 and 59-AGTACCTATCTCCA-GGTCCAATAGGAAC-39 for the mouse rDNA promoter (nucleotide positions of 2110 to +3 relative to transcription start site), and 59-TTGACCAGAGGGACCCCGG-39 and 59-AATAACCCGGCGGCCCA-AAATG-39 for the human rDNA promoter (nucleotide positions of 2182 to 21 relative to transcription start site).
Quantitative RT-PCR
Quantitative determination of pre-rRNA levels by RT-qPCR was carried out essentially as described previously (Murano et al., 2008) . Total RNA was prepared with MagExtractor-RNA (TOYOBO) and treated with RNase-free DNase I (Invitrogen). For analysis of human 45S pre-rRNA, total RNA was subjected to reverse transcription with a primer, 59-ACACACCACCGTTCGGCCTC-39, which corresponds to the 59 external transcribed spacer (ETS) of the human rDNA. The synthesized cDNA was quantitated by real-time PCR using FastStart SYBR Green Master (Roch) in the presence of a primer set, 59-CGTGCGTTCAGGCGTTCTCGTC-39 and 59-CGGCCGGCCAGC-GAGCCGATCG-39, corresponding to the 59 ETS of the human rDNA. For analysis of mouse 45S pre-rRNA, reverse transcription was performed in the presence of a primer, 59-GTATGCAACGCCAC-CGGCCA-39, followed by real-time PCR using a primer set, 59-GATGTGTGAGGCGCCCGGTT-39 and 59-GTATGCAACGCCACC-GGCCA-39. For analysis of mouse b-actin-encoding mRNA, reverse transcription was performed in the presence of oligo(dT) as a primer, followed by real-time PCR using a primer set, 59-TGTTACCA-ACTGGGACGACA-39 and 59-GGGGTGTTGAAGGTCTCAAA-39. For analysis of human b-actin-and c-Myc-encoding mRNA, reverse transcription was performed in the presence of oligo(dT) as a primer, followed by real-time PCR using a primer set, 59-ATGGGTCAGAAG-GATTCCTATGT-39 and 59-GGTCATCTTCTCGCGGTT-39 for bactin, and 59-AGCGACTCTGAGGAGGAACA-39 and 59-CCCTC-TTGGCAGCAGGATAG-39 for c-Myc.
Construction of plasmid vectors
To construct phPolI-vNS-Luc, a DNA fragment of the Luc gene was amplified by PCR with primers, 59-CGTCTCGGGGAGCAAAAG-CAGGGTGACAAAGACATAATGGAAGACGCCAAAAACATAAAG-39 and 59-CGTCTCCTATTAGTAGAAACAAGGGTGTTTTTTATTAT-TACAATTTGGACTTTCCGCCC-39, using PGV-C (TOYO Ink) as a template. The amplified DNA fragment was digested with BsmBI, and then cloned into pHH21 (Neumann et al., 1999) digested with BsmBI. To generate phPolI-vNA-EGFP, phPolI-WSN-NA (Neumann et al., 1999) backbone containing both the 39 and 59 UTR regions of the influenza viral genome was amplified by PCR with primers, 59-TCCGTAGATTGGT-CTTGGCCAGACGG-39 and 59-TCCCATATGTTAAACTCCTGCTTT-CGCTCCCCC-39 using phPolI-WSN-NA as a template. A DNA fragment of EGFP gene was amplified by PCR with primers 59-GGGGAT-CCCATATGGTGAGCAAGGGCGAGGAG-39 and 59-CCGGATCCT-TACTTGTACAGCTCGTCCATGCCG-39 using pEGFP-C1 (Clontech) as a template. The amplified DNA fragment was digested with NdeI and BamHI, and then cloned into the same site of phPolI-WSN-NA backbone. For construction of the IRES-mediated reporter system for Pol I, a DNA fragment of IRES derived from ECMV was generated by PCR amplification from pMX-IRES-GFP with specific primers, 59-CGG-TCTAGATAACGTTACTGGCCGAAGC-39 and 59-CGGTCTAGAAGC-GGCCGCATTGGAATTCCCGGGATCCGGTTGTGGCAAGCTTATCAT-39. The IRES fragment was phosphorylated with T4 polynucleotide kinase and cloned into pHH21, which was digested with KpnI and blunted with T4 DNA polymerase, resulting in construction of phPolI-IRES. The DNA fragment for Luc gene was amplified by PCR using primers 59-CGCGGATCCATGGAAGACGCCAAAAACATAAAGAAAGGC-39 and 59-ATAGTTTAGCGGCCGCTTACAATTTGGACTTTCCGCCCTTCTTG-39 and PGV-C as a template. The amplified PCR product was digested with BamHI and NotI, and cloned into phPolI-IRES digested with BamH I and NotI, resulting in phPolI-IRES-Luc. To construct phPolI-IRES-Luc-PolyA, a DNA fragment of the poly(A) signal (PolyA) was generated by PCR amplification with the primer set 59-GTAAAGCGGCCGCGACTCTA-GATCATAATC-39 and 59-GTAAAGCGGCCGCTTACGCCTTAAGA-TACATTGATGAG-39 using pEGFP-C1 as a template. The amplified fragment was treated with NotI and cloned into the NotI site in phPolI-IRES-Luc, resulting in phPolI-IRES-Luc-PolyA. For expression of Flagtagged UBF1 and UBF2, cDNAs of UBF1 and UBF2 were amplified by PCR with primers, 59-AAAGGATCCATGAACGGAGAAGCCGA-CTG-39 and 59-AAAGAATTCTCAGTTGGAGTCAGAGTCTG-39, using cDNA derived from HeLa cells as a template. The amplified DNA fragments of UBF1 and UBF2 were digested with EcoRI and BamHI and cloned into the EcoRI and BamHI sites of plasmid pcDNA3.1(+)-Flag. To construct expression vectors for human TAF I A, TAF I B, TAF I C and TAF I D, DNA fragments were amplified by PCR using cDNA prepared from HeLa cells. The primers used here were as follows: 59-CTAGCTAGCATGAGTGATTTCAGTGAAGAATTAAAAGGGC-39 and 59-CGCGGATCCTCAGAGTCTTGGATTTACAATACTGTATTTT-39 for TAF I A cDNA, 59-CTAGCTAGCATGGACCTCGAGGAGGCGGAA-39 and 59-CGCGGATCCTCAATGTCGTCTCACTTTCTTGGATCTTG-39 for TAF I B cDNA, 59-CTAGCTAGCATGGACTTCCCCAGCTCCCTC-CG-39 and 59-GGAAGATCTTCAGAAGCCCATTCGAGGCTTCTTCC-39 for TAF I C cDNA, and 59-CTAGCTAGCATGGATAAATCAGGA-ATAGATTCTCTTGACC-39 and 59-GGAAGATCTTCACATTTTCA-GGCCTCTCTGTCCAGTA-39 for TAF I D cDNA. cDNA fragments of TAF I A and B were digested with NheI and BamHI, and cDNA fragments of TAF I C and TAF I D were digested with NheI and BglII. These cDNA fragments were cloned into the restriction site of NheI and BglII in pCHA vector containing an HA epitope tag or pCFlag vector containing the Flag epitope tag. pCFlag was constructed by cloning Flag DNA fragment into EcoRI site of pCAGGS. Flag DNA fragment (91 bp) was generated by PCR and digested with EcoRI. The oligonucleotides used in the PCR were as follows, 59-CCGGAATTC-GCCGCCATGGACTACAAGGATGACGACGACAAGGGCGCTAGC-GGGG-39 and 59-CCGGAATTCAGTCACTTAAGATATCACGCGTG-GTGACCCCGCTAGCGCCCTTGTC-39.
To construct expression vector for mouse TAF I s, cDNA fragments were amplified by PCR using cDNA prepared from A9ch21 cells. The primers used here were as follows: 59-CTAGCTAGCATGATGAGT-GATTTCGGTGAAGAGTTGACA-39 and 59-CGCACGCGTCTAGGT-GTGAACACCTGGATTTACAATAGT-39 for TAF I A cDNA, 59-CTAGCTAGCATGGATGTGGAGGAGGTGAAAGCGTTCA-39 and 59-CGCACGCGTTCAGTGTCTTCTTCCTTTCTTGGATCCTGA-39 for TAF I B cDNA, 59-CGCACGCGTATGGACTTCCCTGGCACCCTGCG-39 and 59-GGAAGATCTTCAGAAGCCCATTCGTGGCTTCTTCTGG-39 for TAF I C cDNA, and 59-CTAGCTAGCATGGCTCAATCAGAAG-TGAATTCTGTCTGT-39 and 59-GGAAGATCTTTATCTATGTTCTT-TACCTTCTTCAATAGTC-39 for TAF I D cDNA. These cDNA fragments of TAF I A and B were digested with NheI and MluI, and cloned into the restriction site of NheI and MluI in pCFlag vector containing the Flag epitope tag. The cDNA fragment of TAF I C was digested with MluI and BglII, and cloned into the MluI and BglII site in pCFlag. The cDNA fragments of TAF I D was digested with NheI and BglII, and cloned into NheI and BglII site in pCFlag.
To generate phPolI-Dcore-vNS-Luc, phPolI-DUCE-vNS-Luc and phPolI-G-7,-16A-vNS-Luc, phPolI-vNS-Luc used as template for amplification by PCR with primers, 59-CGAAAGATATACCTCC-CCCGG-39 and 59-GTTATTAGTAGAAACAAGGGTGTTTTTTATT-ATTA-39, 59-AGCCACACACGGAGCGCCCG-39 and 59-GTCCGTGT-CGCGCGTCGCCT-39, and 59-AGTTATTAGTAGAAACAAGGGT-GTTTTTTATTATTA-39 and 59-CGGCGGCCTAAAATGCCGACTC-GGA-39, respectively. These DNA fragments were phosphorylated by T4 polynucleotide kinase, followed by ligation. To generate pmPolI-DcorevNS-Luc, pmPolI-DUCE-vNS-Luc, and pmPolI-G-7,-16A-vNS-Luc, pmPolI-vNS-Luc were used as template for amplification by PCR with primers 59-ATAGGTAGTAGAAACAAGGGTGTTTTTTA-39 and 59-AACAGATAGAAAAGATCACAAGCATAAAAG-39, 59-ACCTCCA-CAGGTATGACTTCCAGGT-39 and 59-CGGACCTCAAAGGAAC-AACTGGT-39, and 59-AATAGGTAGTAGAAACAAGGGTGTTTTT-TA-39 and 59-TCCAGGTCTAATAGGAACAGATAG-39, respectively. These DNA fragments were phosphorylated by T4 polynucleotide kinase, followed by ligation. The structure of human and mouse rDNA promoter regions in these plasmids is represented on Fig. 2 .
